I guess we get to keep the lights on after all.  I lightened my position considerably after listening to AGM and thought regardless of Covid excuse we didn't get any real information on deal with industry partner etc. meaning no one is on board yet. At least that was my read, just lip service.

Looking at Bears post on the number of companies working on Covid Vaccines and Therapeutics etc. doesn't look like the Covid angle is a big deal for RVX. Just starting trials in January makes them a late starter.

I always thought Apabetolone was a winner it seems to help your Heart, Kidneys, Liver, Arteries, Brain and maybe even assist in Covid.  They could plan on going it alone with the new investor et al backing a big tranche of new money in the new year after he gets his seed capital. I think they need an industry partner though.

Good, they are raising the $13 million but I am convinced they need to list on the Nasdaq with some of that $13 million. That doesn't seem to be a priority with DM but that is where RVX is wrong in my view. In order to do that you may need a new Maestro at the helm or a complete paradigm shift in thinking. Good Luck everyone I hope this works out. I've kept some shares but am not expecting much and if they don't advance this further in the 1st qtr. then it is Hasta las vista for me. Not following it unless my Alert button pings if it hits over $2 or under $.50. Life is too short.

This is an excellent board and has been a real pleasure to follow and I hope they hit a home run that I don't see coming. All the Best.